APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-wearable Dosimetry

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-wearable Dosimetry Market Outlook and Growth Opportunities 2026

25 December 2025195 pages

Choose your research edition.

Industry ResearchNon-wearable Dosimetry Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-wearable Dosimetry Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Non-wearable Dosimetry Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-wearable Dosimetry Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-wearable Dosimetry Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Non-wearable Dosimetry market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-wearable Dosimetry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-wearable Dosimetry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-wearable Dosimetry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-wearable Dosimetry market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-wearable Dosimetry market include Fuji Electric Corporation of America, Honeywell, Fisher Scientific, S.E. International, Polimaster, Mirion Technologies, Ludlum Measurements, Laurus Systems and Landauer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-wearable Dosimetry market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-wearable Dosimetry and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-wearable Dosimetry sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-wearable Dosimetry market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-wearable Dosimetry Segment by Company

Fuji Electric Corporation of America

Honeywell

Fisher Scientific

S.E. International

Polimaster

Mirion Technologies

Ludlum Measurements

Laurus Systems

Landauer

JP Laboratories

Far West Technology

Non-wearable Dosimetry Segment by Type

Processed Dosimeters

Personal Electronic Dosimeter

Self-reading Dosimeters

Non-wearable Dosimetry Segment by Application

Industrial

Oil and Gas

Medical

Other

Non-wearable Dosimetry Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non-wearable Dosimetry status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Non-wearable Dosimetry market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-wearable Dosimetry significant trends, drivers, influence factors in global and regions.

6. To analyze Non-wearable Dosimetry competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-wearable Dosimetry market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-wearable Dosimetry and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-wearable Dosimetry.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-wearable Dosimetry market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-wearable Dosimetry industry.

Chapter 3: Detailed analysis of Non-wearable Dosimetry manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Non-wearable Dosimetry in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Non-wearable Dosimetry in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-wearable Dosimetry Industry Trends Table 2. Non-wearable Dosimetry Industry Drivers Table 3. Non-wearable Dosimetry Industry Opportunities and Challenges Table 4. Non-wearable Dosimetry Industry Restraints Table 5. Global Non-wearable Dosimetry Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-wearable Dosimetry Revenue Share by Company (2021-2026) Table 7. Global Non-wearable Dosimetry Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Non-wearable Dosimetry Sales Volume Share by Company (2021-2026) Table 9. Global Non-wearable Dosimetry Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Non-wearable Dosimetry Company Ranking, (2024-2026) & (USD Million) Table 11. Global Non-wearable Dosimetry Key Company Manufacturing Base & Headquarters Table 12. Global Non-wearable Dosimetry Company, Product Type & Application Table 13. Global Non-wearable Dosimetry Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-wearable Dosimetry by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Processed Dosimeters Table 18. Significant Companies of Personal Electronic Dosimeter Table 19. Significant Companies of Self-reading Dosimeters Table 20. Global Non-wearable Dosimetry Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Non-wearable Dosimetry Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Non-wearable Dosimetry Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Non-wearable Dosimetry Sales Volume Share by Type (2021-2026) Table 24. Global Non-wearable Dosimetry Sales Volume Share by Type (2027-2032) Table 25. Global Non-wearable Dosimetry Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Non-wearable Dosimetry Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Non-wearable Dosimetry Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Non-wearable Dosimetry Sales Value Share by Type (2021-2026) Table 29. Global Non-wearable Dosimetry Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Industrial Table 31. Significant Companies of Oil and Gas Table 32. Significant Companies of Medical Table 33. Significant Companies of Other Table 34. Global Non-wearable Dosimetry Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Non-wearable Dosimetry Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Non-wearable Dosimetry Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Non-wearable Dosimetry Sales Volume Share by Application (2021-2026) Table 38. Global Non-wearable Dosimetry Sales Volume Share by Application (2027-2032) Table 39. Global Non-wearable Dosimetry Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Non-wearable Dosimetry Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Non-wearable Dosimetry Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Non-wearable Dosimetry Sales Value Share by Application (2021-2026) Table 43. Global Non-wearable Dosimetry Sales Value Share by Application (2027-2032) Table 44. Global Non-wearable Dosimetry Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Non-wearable Dosimetry Sales by Region (2021-2026) & (K Units) Table 46. Global Non-wearable Dosimetry Sales Market Share by Region (2021-2026) Table 47. Global Non-wearable Dosimetry Sales by Region (2027-2032) & (K Units) Table 48. Global Non-wearable Dosimetry Sales Market Share by Region (2027-2032) Table 49. Global Non-wearable Dosimetry Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Non-wearable Dosimetry Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Non-wearable Dosimetry Sales Value Share by Region (2021-2026) Table 52. Global Non-wearable Dosimetry Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Non-wearable Dosimetry Sales Value Share by Region (2027-2032) Table 54. Global Non-wearable Dosimetry Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Non-wearable Dosimetry Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Non-wearable Dosimetry Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Non-wearable Dosimetry Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Non-wearable Dosimetry Sales by Country (2021-2026) & (K Units) Table 59. Global Non-wearable Dosimetry Sales Market Share by Country (2021-2026) Table 60. Global Non-wearable Dosimetry Sales by Country (2027-2032) & (K Units) Table 61. Global Non-wearable Dosimetry Sales Market Share by Country (2027-2032) Table 62. Global Non-wearable Dosimetry Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Non-wearable Dosimetry Sales Value Market Share by Country (2021-2026) Table 64. Global Non-wearable Dosimetry Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Non-wearable Dosimetry Sales Value Market Share by Country (2027-2032) Table 66. Fuji Electric Corporation of America Company Information Table 67. Fuji Electric Corporation of America Business Overview Table 68. Fuji Electric Corporation of America Non-wearable Dosimetry Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Fuji Electric Corporation of America Non-wearable Dosimetry Product Portfolio Table 70. Fuji Electric Corporation of America Recent Development Table 71. Honeywell Company Information Table 72. Honeywell Business Overview Table 73. Honeywell Non-wearable Dosimetry Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Honeywell Non-wearable Dosimetry Product Portfolio Table 75. Honeywell Recent Development Table 76. Fisher Scientific Company Information Table 77. Fisher Scientific Business Overview Table 78. Fisher Scientific Non-wearable Dosimetry Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Fisher Scientific Non-wearable Dosimetry Product Portfolio Table 80. Fisher Scientific Recent Development Table 81. S.E. International Company Information Table 82. S.E. International Business Overview Table 83. S.E. International Non-wearable Dosimetry Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. S.E. International Non-wearable Dosimetry Product Portfolio Table 85. S.E. International Recent Development Table 86. Polimaster Company Information Table 87. Polimaster Business Overview Table 88. Polimaster Non-wearable Dosimetry Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Polimaster Non-wearable Dosimetry Product Portfolio Table 90. Polimaster Recent Development Table 91. Mirion Technologies Company Information Table 92. Mirion Technologies Business Overview Table 93. Mirion Technologies Non-wearable Dosimetry Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Mirion Technologies Non-wearable Dosimetry Product Portfolio Table 95. Mirion Technologies Recent Development Table 96. Ludlum Measurements Company Information Table 97. Ludlum Measurements Business Overview Table 98. Ludlum Measurements Non-wearable Dosimetry Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Ludlum Measurements Non-wearable Dosimetry Product Portfolio Table 100. Ludlum Measurements Recent Development Table 101. Laurus Systems Company Information Table 102. Laurus Systems Business Overview Table 103. Laurus Systems Non-wearable Dosimetry Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Laurus Systems Non-wearable Dosimetry Product Portfolio Table 105. Laurus Systems Recent Development Table 106. Landauer Company Information Table 107. Landauer Business Overview Table 108. Landauer Non-wearable Dosimetry Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Landauer Non-wearable Dosimetry Product Portfolio Table 110. Landauer Recent Development Table 111. JP Laboratories Company Information Table 112. JP Laboratories Business Overview Table 113. JP Laboratories Non-wearable Dosimetry Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. JP Laboratories Non-wearable Dosimetry Product Portfolio Table 115. JP Laboratories Recent Development Table 116. Far West Technology Company Information Table 117. Far West Technology Business Overview Table 118. Far West Technology Non-wearable Dosimetry Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Far West Technology Non-wearable Dosimetry Product Portfolio Table 120. Far West Technology Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. Non-wearable Dosimetry Distributors List Table 124. Non-wearable Dosimetry Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Non-wearable Dosimetry Product Image Figure 2. Global Non-wearable Dosimetry Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-wearable Dosimetry Sales Value (2021-2032) & (US$ Million) Figure 4. Global Non-wearable Dosimetry Sales (2021-2032) & (K Units) Figure 5. Global Non-wearable Dosimetry Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Non-wearable Dosimetry Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Processed Dosimeters Image Figure 10. Personal Electronic Dosimeter Image Figure 11. Self-reading Dosimeters Image Figure 12. Global Non-wearable Dosimetry Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Non-wearable Dosimetry Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Non-wearable Dosimetry Sales Volume Share by Type (2021-2032) Figure 15. Global Non-wearable Dosimetry Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Non-wearable Dosimetry Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Non-wearable Dosimetry Sales Value Share by Type (2021-2032) Figure 18. Industrial Image Figure 19. Oil and Gas Image Figure 20. Medical Image Figure 21. Other Image Figure 22. Global Non-wearable Dosimetry Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Non-wearable Dosimetry Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Non-wearable Dosimetry Sales Volume Share by Application (2021-2032) Figure 25. Global Non-wearable Dosimetry Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Non-wearable Dosimetry Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Non-wearable Dosimetry Sales Value Share by Application (2021-2032) Figure 28. Global Non-wearable Dosimetry Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Non-wearable Dosimetry Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Non-wearable Dosimetry Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Non-wearable Dosimetry Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Non-wearable Dosimetry Sales Value (2021-2032) & (US$ Million) Figure 33. North America Non-wearable Dosimetry Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Non-wearable Dosimetry Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Non-wearable Dosimetry Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Non-wearable Dosimetry Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Non-wearable Dosimetry Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Non-wearable Dosimetry Sales Value (2021-2032) & (US$ Million) Figure 39. South America Non-wearable Dosimetry Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Non-wearable Dosimetry Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Non-wearable Dosimetry Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Non-wearable Dosimetry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Non-wearable Dosimetry Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Non-wearable Dosimetry Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Processed Dosimeters
  • Personal Electronic Dosimeter
  • Self-reading Dosimeters
Applications
  • Industrial
  • Oil and Gas
  • Medical
  • Other
Companies covered
  • Fuji Electric Corporation of America
  • Honeywell
  • Fisher Scientific
  • S.E. International
  • Polimaster
  • Mirion Technologies
  • Ludlum Measurements
  • Laurus Systems
  • Landauer
  • JP Laboratories
  • Far West Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-wearable Dosimetry Sales Value (2021-2032)
  4. 1.2.2 Global Non-wearable Dosimetry Sales Volume (2021-2032)
  5. 1.2.3 Global Non-wearable Dosimetry Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Non-wearable Dosimetry Market Dynamics
  1. 2.1 Non-wearable Dosimetry Industry Trends
  2. 2.2 Non-wearable Dosimetry Industry Drivers
  3. 2.3 Non-wearable Dosimetry Industry Opportunities and Challenges
  4. 2.4 Non-wearable Dosimetry Industry Restraints
3 Non-wearable Dosimetry Market by Company
  1. 3.1 Global Non-wearable Dosimetry Company Revenue Ranking in 2025
  2. 3.2 Global Non-wearable Dosimetry Revenue by Company (2021-2026)
  3. 3.3 Global Non-wearable Dosimetry Sales Volume by Company (2021-2026)
  4. 3.4 Global Non-wearable Dosimetry Average Price by Company (2021-2026)
  5. 3.5 Global Non-wearable Dosimetry Company Ranking (2024-2026)
  6. 3.6 Global Non-wearable Dosimetry Company Manufacturing Base and Headquarters
  7. 3.7 Global Non-wearable Dosimetry Company Product Type and Application
  8. 3.8 Global Non-wearable Dosimetry Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Non-wearable Dosimetry Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Non-wearable Dosimetry Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Non-wearable Dosimetry Market by Type
  1. 4.1 Non-wearable Dosimetry Type Introduction
  2. 4.1.1 Processed Dosimeters
  3. 4.1.2 Personal Electronic Dosimeter
  4. 4.1.3 Self-reading Dosimeters
  5. 4.2 Global Non-wearable Dosimetry Sales Volume by Type
  6. 4.2.1 Global Non-wearable Dosimetry Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Non-wearable Dosimetry Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Non-wearable Dosimetry Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Non-wearable Dosimetry Sales Value by Type
  10. 4.3.1 Global Non-wearable Dosimetry Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Non-wearable Dosimetry Sales Value by Type (2021-2032)
  12. 4.3.3 Global Non-wearable Dosimetry Sales Value Share by Type (2021-2032)
5 Non-wearable Dosimetry Market by Application
  1. 5.1 Non-wearable Dosimetry Application Introduction
  2. 5.1.1 Industrial
  3. 5.1.2 Oil and Gas
  4. 5.1.3 Medical
  5. 5.1.4 Other
  6. 5.2 Global Non-wearable Dosimetry Sales Volume by Application
  7. 5.2.1 Global Non-wearable Dosimetry Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Non-wearable Dosimetry Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Non-wearable Dosimetry Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Non-wearable Dosimetry Sales Value by Application
  11. 5.3.1 Global Non-wearable Dosimetry Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Non-wearable Dosimetry Sales Value by Application (2021-2032)
  13. 5.3.3 Global Non-wearable Dosimetry Sales Value Share by Application (2021-2032)
6 Non-wearable Dosimetry Regional Sales and Value Analysis
  1. 6.1 Global Non-wearable Dosimetry Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-wearable Dosimetry Sales by Region (2021-2032)
  3. 6.2.1 Global Non-wearable Dosimetry Sales by Region: 2021-2026
  4. 6.2.2 Global Non-wearable Dosimetry Sales by Region (2027-2032)
  5. 6.3 Global Non-wearable Dosimetry Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Non-wearable Dosimetry Sales Value by Region (2021-2032)
  7. 6.4.1 Global Non-wearable Dosimetry Sales Value by Region: 2021-2026
  8. 6.4.2 Global Non-wearable Dosimetry Sales Value by Region (2027-2032)
  9. 6.5 Global Non-wearable Dosimetry Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Non-wearable Dosimetry Sales Value (2021-2032)
  12. 6.6.2 North America Non-wearable Dosimetry Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Non-wearable Dosimetry Sales Value (2021-2032)
  15. 6.7.2 Europe Non-wearable Dosimetry Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Non-wearable Dosimetry Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Non-wearable Dosimetry Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Non-wearable Dosimetry Sales Value (2021-2032)
  21. 6.9.2 South America Non-wearable Dosimetry Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Non-wearable Dosimetry Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Non-wearable Dosimetry Sales Value Share by Country, 2025 VS 2032
7 Non-wearable Dosimetry Country-level Sales and Value Analysis
  1. 7.1 Global Non-wearable Dosimetry Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-wearable Dosimetry Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Non-wearable Dosimetry Sales by Country (2021-2032)
  4. 7.3.1 Global Non-wearable Dosimetry Sales by Country (2021-2026)
  5. 7.3.2 Global Non-wearable Dosimetry Sales by Country (2027-2032)
  6. 7.4 Global Non-wearable Dosimetry Sales Value by Country (2021-2032)
  7. 7.4.1 Global Non-wearable Dosimetry Sales Value by Country (2021-2026)
  8. 7.4.2 Global Non-wearable Dosimetry Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Non-wearable Dosimetry Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Non-wearable Dosimetry Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Non-wearable Dosimetry Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Fuji Electric Corporation of America
  2. 8.1.1 Fuji Electric Corporation of America Company Information
  3. 8.1.2 Fuji Electric Corporation of America Business Overview
  4. 8.1.3 Fuji Electric Corporation of America Non-wearable Dosimetry Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Fuji Electric Corporation of America Non-wearable Dosimetry Product Portfolio
  6. 8.1.5 Fuji Electric Corporation of America Recent Developments
  7. 8.2 Honeywell
  8. 8.2.1 Honeywell Company Information
  9. 8.2.2 Honeywell Business Overview
  10. 8.2.3 Honeywell Non-wearable Dosimetry Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Honeywell Non-wearable Dosimetry Product Portfolio
  12. 8.2.5 Honeywell Recent Developments
  13. 8.3 Fisher Scientific
  14. 8.3.1 Fisher Scientific Company Information
  15. 8.3.2 Fisher Scientific Business Overview
  16. 8.3.3 Fisher Scientific Non-wearable Dosimetry Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Fisher Scientific Non-wearable Dosimetry Product Portfolio
  18. 8.3.5 Fisher Scientific Recent Developments
  19. 8.4 S.E. International
  20. 8.4.1 S.E. International Company Information
  21. 8.4.2 S.E. International Business Overview
  22. 8.4.3 S.E. International Non-wearable Dosimetry Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 S.E. International Non-wearable Dosimetry Product Portfolio
  24. 8.4.5 S.E. International Recent Developments
  25. 8.5 Polimaster
  26. 8.5.1 Polimaster Company Information
  27. 8.5.2 Polimaster Business Overview
  28. 8.5.3 Polimaster Non-wearable Dosimetry Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Polimaster Non-wearable Dosimetry Product Portfolio
  30. 8.5.5 Polimaster Recent Developments
  31. 8.6 Mirion Technologies
  32. 8.6.1 Mirion Technologies Company Information
  33. 8.6.2 Mirion Technologies Business Overview
  34. 8.6.3 Mirion Technologies Non-wearable Dosimetry Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mirion Technologies Non-wearable Dosimetry Product Portfolio
  36. 8.6.5 Mirion Technologies Recent Developments
  37. 8.7 Ludlum Measurements
  38. 8.7.1 Ludlum Measurements Company Information
  39. 8.7.2 Ludlum Measurements Business Overview
  40. 8.7.3 Ludlum Measurements Non-wearable Dosimetry Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Ludlum Measurements Non-wearable Dosimetry Product Portfolio
  42. 8.7.5 Ludlum Measurements Recent Developments
  43. 8.8 Laurus Systems
  44. 8.8.1 Laurus Systems Company Information
  45. 8.8.2 Laurus Systems Business Overview
  46. 8.8.3 Laurus Systems Non-wearable Dosimetry Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Laurus Systems Non-wearable Dosimetry Product Portfolio
  48. 8.8.5 Laurus Systems Recent Developments
  49. 8.9 Landauer
  50. 8.9.1 Landauer Company Information
  51. 8.9.2 Landauer Business Overview
  52. 8.9.3 Landauer Non-wearable Dosimetry Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Landauer Non-wearable Dosimetry Product Portfolio
  54. 8.9.5 Landauer Recent Developments
  55. 8.10 JP Laboratories
  56. 8.10.1 JP Laboratories Company Information
  57. 8.10.2 JP Laboratories Business Overview
  58. 8.10.3 JP Laboratories Non-wearable Dosimetry Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 JP Laboratories Non-wearable Dosimetry Product Portfolio
  60. 8.10.5 JP Laboratories Recent Developments
  61. 8.11 Far West Technology
  62. 8.11.1 Far West Technology Company Information
  63. 8.11.2 Far West Technology Business Overview
  64. 8.11.3 Far West Technology Non-wearable Dosimetry Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Far West Technology Non-wearable Dosimetry Product Portfolio
  66. 8.11.5 Far West Technology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-wearable Dosimetry Value Chain Analysis
  2. 9.1.1 Non-wearable Dosimetry Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-wearable Dosimetry Sales Mode & Process
  6. 9.2 Non-wearable Dosimetry Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-wearable Dosimetry Distributors
  9. 9.2.3 Non-wearable Dosimetry Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst